NCT03541616View on ClinicalTrials.gov

Prevalence of Subclinical Atrial Fibrillation in Heart Failure Patients and Its Relationship With Hospital Readmission

CompletedOBSERVATIONAL
Enrollment

242

Participants

Timeline

Start Date

March 24, 2018

Primary Completion Date

January 31, 2022

Study Completion Date

March 27, 2023

Conditions
Heart FailureAtrial Fibrillation
Interventions
DEVICE

ECG Patch, pocket ECG monitor

Two consecutive 14-day ECG monitor patches or one single 28-day pocket ECG monitor (28-days total monitoring) implemented at the time of hospital discharge .

Trial Locations (5)

Unknown

Hamilton General Hospital, Hamilton

Juravinski Hospital, Hamilton

St. Joseph's Healthcare Hamilton, Hamilton

N2M1B2

St. Mary's Hospital, Kitchener

L2S0A9

St. Catherines General Hospital, St. Catharines

Sponsors
All Listed Sponsors
collaborator

Heart and Stroke Foundation of Canada

OTHER

collaborator

Canadian Cardiovascular Society

OTHER

lead

Population Health Research Institute

OTHER

NCT03541616 - Prevalence of Subclinical Atrial Fibrillation in Heart Failure Patients and Its Relationship With Hospital Readmission | Biotech Hunter | Biotech Hunter